FHIR IG analytics| Package | hl7.fhir.uv.pharm-quality |
| Resource Type | Composition |
| Id | Composition-composition-drug-pq-risk.json |
| FHIR Version | R5 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: Composition
Resource Composition "composition-drug-pq-risk"
Profile: Composition - Drug PQ
status: final
type: Product Note - Summary for Risk of Impurities ()
date: 2023-10-01
author: Organization/organization-drug-pq-ex1 "AAA Molybdenum Products, Inc."
title: 3.2.P.2.2.4 - Summary for Risk of Impurities
{
"resourceType": "Composition",
"id": "composition-drug-pq-risk",
"meta": {
"profile": [
"http://hl7.org/fhir/uv/pharm-quality/StructureDefinition/Composition-drug-pq"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"status": "final",
"type": {
"text": "Product Note - Summary for Risk of Impurities"
},
"subject": [
{
"reference": "MedicinalProductDefinition/medicinalproductdefinition-drug-product-pq-ex1"
}
],
"date": "2023-10-01",
"author": [
{
"reference": "Organization/organization-drug-pq-ex1"
}
],
"title": "3.2.P.2.2.4 - Summary for Risk of Impurities",
"section": [
{
"text": {
"status": "additional",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <p>Text for the risk assessment of elemental impurities in the product</p>\n </div>"
}
}
]
}